Skip to search formSkip to main contentSkip to account menu

diamminedichlorodihydroxyplatinum IV

Known as: oxoplatinum, dichlorodihydroxyammineplatinum, oxoplatina 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
As FDA-approved chemotherapeutic agents, cisplatin, oxaliplatin, and 5-fluorouracil are widely used in clinic but limited by… 
Highly Cited
2015
Highly Cited
2015
Combinational chemotherapy is often used to prevent drug induced resistance in cancer. The aim of this work is to test whether… 
2014
2014
The biodistribution of micelles with and without folic acid targeting ligands were studied using a block copolymer consisting of… 
Highly Cited
2013
Highly Cited
2013
In this study, a novel technique was used for the reversible attachment of folic acid on the surface of polymeric micelles for a… 
Highly Cited
2013
Highly Cited
2013
In this work, we explore the use of a quick coupling mechanism for "arming" a cyclodextrin coated gold nanoparticle (AuNP… 
Highly Cited
2009
Highly Cited
2009
Multinuclear platinum anticancer complexes are a proven option to overcome resistance of established anticancer compounds… 
2009
2009
Platinum(IV) compounds like oxoplatin (cis, cis, trans-diammine-dichlorido-dihydroxido-platinum(IV)) show increased stability and… 
2000
2000
Cisplatin is a widely used anticancer drug, but its application is limited due to severe side effects. To reduce these effects… 
1995
1995
A sensitive postcolumn derivatization/UV detection system has been developed for HPLC analysis of antitumor divalent and…